Ali Entezam

Ali Entezam, PhD, currently serves as the Strategic Director of Clinical Genomic Variant Sciences at LabCorp. They previously held positions at Invitae as Team Leader and Clinical Genomics Scientist, where they focused on variant interpretation, report writing, and workflow development. Prior to this, Ali worked at GeneDx as an Assistant Director and Molecular Diagnostic Review Analyst, leading major transitions in data analysis workflows and managing a team of Review Analysts. Their early career involved significant research and collaboration at the National Institutes of Health, where they published numerous articles on genetic disorders and molecular evolution. Ali is also pursuing multiple degrees in biotechnology and molecular genetics from esteemed institutions.